Sasan Fallahi

Sasan Fallahi

Auto-generated profile, based on publicly available information

Sasan Fallahi

Internal Medicine Division, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2016 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
SFSasan Fallahi
Sasan Fallahi
AJAhmad Reza Jamshidi
Ahmad Reza Jamshidi
Objectives: This study aims to evaluate diagnostic delay, factors which are related to diagnostic delay, and the effect of diagnostic delay on prognostic outcomes in terms of spinal and hip mobility, functional status, disease activity, quality of life, cervical rotation, tragus to wall distance, and sacroiliitis severity in an Iranian population with ankylosing spondylitis (AS). Materials and methods: One hundred and sixty three patients (129 males, 34 females; mean age 37.74±9.88 years; range 18 to 65 years) with AS who met modified New York 1984 criteria were enrolled consecutively in a cross sectional survey. The main outcome variable (diagnostic delay) was defined as the interval between appearance of first symptoms and correct diagnosis of AS. Enthesitis, negative human leukocyte antigen B27 (HLA- B27), and educational level were among the factors of which their relationship to diagnostic delay were evaluated. The prognostic outcomes were measured using Bath ankylosing spondylitis functional index, Bath ankylosing spondylitis disease activity index, AS quality of life, Bath ankylosing spondylitis metrology index, chest expansion, and radiographic sacroiliitis severity. Results: Diagnostic delay was mean 7.88±7.17 years. Diagnostic delay was longer in patients with enthesitis (8.80±7.27) compared to patients without enthesitis (6.04±6.66) (p=0.007) and in HLA-B27 negative patients (10.10±7.44) compared to HLA-B27 positive patients (7.14±6.96) (p=0.013). Educational level was negatively correlated with diagnostic delay (p=0.002, r= -0.24). Diagnostic delay was correlated with Bath ankylosing spondylitis functional index (p=0.003, r=0.23), Bath ankylosing spondylitis disease activity index (p=0.026, r=0.18), AS quality of life (p=0.008, r=0.21), Bath ankylosing spondylitis metrology index (p

28 November 2013 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ASAbtin Shahlaee
Abtin Shahlaee
MMMahdi Mahmoudi
Mahdi Mahmoudi
SSSajjad Shekarchian
Sajjad Shekarchian
EFElham Farhadi
Elham Farhadi
SFSasan Fallahi
Sasan Fallahi
AJAhmadreza Jamshidi
Ahmadreza Jamshidi


1 December 2012
Verified
Journal Article
Closed access
MMMahdi Mahmoudi
Mahdi Mahmoudi
AJAhmad Reza Jamshidi
Ahmad Reza Jamshidi
AAAli Akbar Amirzargar
Ali Akbar Amirzargar
EFElham Farhadi
Elham Farhadi
KNKeramat Nourijelyani
Keramat Nourijelyani
SSSajjad Shekarchian
Sajjad Shekarchian

18 October 2013 in Modern Rheumatology
Verified
Journal Article
Closed access
AJAhmad Reza Jamshidi
Ahmad Reza Jamshidi
ASAbtin Shahlaee
Abtin Shahlaee
EFElham Farhadi
Elham Farhadi
SFSasan Fallahi
Sasan Fallahi
SSSajjad Shekarchian
Sajjad Shekarchian
MMMahdi Mahmoudi
Mahdi Mahmoudi
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease with variable clinical expression. Ethnic, racial and geographical factors have been associated with disease occurrence and expression. We intended to describe the clinical characteristics and assess the disease severity and treatment status in Iranian AS patients. A total of 320 AS patients were assessed for demographic variables, clinical manifestations, human leukocyte antigen (HLA) status, disease severity, functional capacities, quality of life and treatment status. A gender ratio of 3.8:1, an average age onset of 27 ± 7.3 and a mean diagnostic delay of 8 years were observed. Eleven percent had juvenile onset AS. Positive family history was higher than that observed in most other countries. Enthesitis was a very common finding involving more than two-thirds of our patients. Uveitis was the leading extra-articular manifestation. We found an HLA-B27 prevalence of 73% and four HLA-B27 subtypes. Disease activity was high and the functional status was poor as indicated by mean Bath AS Disease Activity, Functional and Metrology indices. Quality of life was considerably impaired in our patients. We found a low percentage of patients on biological medications and a relatively higher percentage on disease modifying anti-rheumatic drugs and corticosteroids. Our results demonstrate a broad characterization of Iranian AS patients providing a better understanding of this disease. A national multicenter registry would enable larger- scale prospective studies to be carried out further evaluating the disease burden on patients and society.

1 December 2013
Verified
Journal Article
Closed access
SFSasan Fallahi
Sasan Fallahi
MMMahdi Mahmoudi
Mahdi Mahmoudi
SSSajjad Shekarchian
Sajjad Shekarchian
FGFarhad Gharibdoost
Farhad Gharibdoost
EFElham Farhadi
Elham Farhadi
AJAhmad Reza Jamshidi
Ahmad Reza Jamshidi